The U.S. Court of Appeals for the Second Circuit recently issued a 2-1 decision in In re Vitamin C Antitrust Litig., dismissing antitrust claims against two Chinese pharmaceutical companies for reasons of international comity in a case that has lasted over 15 years. [1] On August 10, 2021, the Second Circuit held there was a “true conflict” between U.S. law and Chinese law because Chinese law required the price fixing at issue. Weighing this with the remaining factors in a comity analysis, the Second Circuit found that dismissal was warranted. Earlier in the proceedings, the Chinese government made its first official appearance in a U.S. court through submission of an amicus brief. The Second Circuit previously ruled in favor of dismissal in deference to the Chinese government’s
Share on
|
|
The US Court of Appeals for the Second Circuit dismisses antitrust claims against two Chinese pharmaceutical companies for reasons of international comity (Animal Science Products / Hebei Welcome Pharmaceutical)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
